---
layout: default
title: Publications
subtitle: Liguo Wang's Bibliography
---


## Publications 

---

***\* first author, \# corresponding author***


### 2021

1. Wu D, **Wang L**, Huang H. Protocol for capture of massive histone acetylation. **STAR Protocols** 2021 (accepted)

2. Wei T, Lu J, Ma T, Huang H, Kocher JP, **Wang L**#. Re-evaluate fusion genes in prostate cancer. **Cancer Informatics** 2021 Jun 21; doi: 10.1177/11769351211027592. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/34234399/)


3. Huang Z, Tang B, Yang Y, Yang Z, Shi L, Bai Y, Yan B, Karnes RJ, Zhang J, Jimenez R, **Wang L**, Wei Q, Yang J, Xu W, Jia Z, Huang H. MAP3K7-IKK inflammatory signaling modulates AR protein degradation and prostate cancer progression. **Cancer Res**. 2021 Jun 22:canres.4194.2020. doi: 10.1158/0008-5472.CAN-20-4194. Epub ahead of print. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/34158377/)

4. Wang D, Ma J, Botuyan MV, Cui G, Yan Y, Ding D, Zhou Y, Krueger EW, Pei J, Wu X, **Wang L** , Pei H, McNiven MA, Ye D, Mer G, Huang H. ATM-phosphorylated SPOP contributes to 53BP1 exclusion from chromatin during DNA replication. **Sci Adv.** 2021 Jun; 7 (25) Epub 2021 June 18. doi: 10.1126/sciadv.abd9208 [View PubMed](https://pubmed.ncbi.nlm.nih.gov/34144977/)

5. He Y, **Wang L**, Wei T, Xiao YT, Sheng H, Su H, Hollern DP, Zhang X, Ma J, Wen S, Xie H, Yan Y, Pan Y, Hou X, Tang X, Suman VJ, Carter JM, Weinshilboum R, Wang L, Kalari KR, Weroha SJ, Bryce AH, Boughey JC, Dong H, Perou CM, Ye D, Goetz MP, Ren S, Huang H. FOXA1 overexpression suppresses interferon signaling and immune response in cancer. **J Clin Invest**. 2021 Jun 8 Epub 2021 June 08. doi: 10.1172/JCI147025 [View PubMed](https://pubmed.ncbi.nlm.nih.gov/34101624/)

6. Zhou Y, Jin X, Ma J, Ding D, Huang Z, Sheng H, Yan Y, Pan Y, Wei T, **Wang L**, Wu H, Huang H. HDAC5 loss impairs RB repression of pro-oncogenic genes and confers CDK4/6 inhibitor resistance in cancer. **Cancer Res**. 2021 Jan 8;. doi: 10.1158/0008-5472.CAN-20-2828. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/33419772/)

7. El Khoury LY, Fu S, Hlady RA, Wagner RT, **Wang L**, Eckel-Passow JE, Castle EP, Stanton ML, Thompson RH, Parker AS, Ho TH, Robertson KD. Identification of DNA methylation signatures associated with poor outcome in lower-risk Stage, Size, Grade and Necrosis (SSIGN) score clear cell renal cell cancer. **Clin Epigenetics** 2021 Jan 18; 13(1):12. doi: 10.1186/s13148-020-00998-z. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/33461589/)

8. Wu D, Yan Y, Wei T, Ye Z, Xiao Y, Pan Y, Orme J, Wang D, **Wang L**#, Ren S#, Huang H#. An acetyl-histone vulnerability in PI3K/AKT inhibition-resistant cancers is targetable by both BET and HDAC inhibitors. **Cell Rep**. 2021 Feb 16;34(7):108744. doi: 10.1016/j.celrep.2021.108744. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/33596421/)

9. Tang B, Sun R, Wang D, Sheng H, Wei T, **Wang L**, Zhang J, Ho TH, Yang L, Wei Q, Huang H. ZMYND8 preferentially binds phosphorylated EZH2 to promote a PRC2-dependent to -independent function switch in hypoxia-inducible factorâ€“activated cancer. **Proc Natl Acad Sci USA** February 23, 2021 118 (8) e2019052118; doi: 10.1073/pnas.2019052118. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/33593912/)

10. He Y, Wei T, Ye Z, Orme JJ, Lin D, Sheng H, Fazli L, Jeffrey Karnes R, Jimenez R, **Wang L**, Wang L, Gleave ME, Wang Y, Shi L, Huang H. A noncanonical AR addiction drives enzalutamide resistance in prostate cancer. **Nat Commun**. 2021 Mar 9; 12 (1):1521 Epub 2021 Mar 09. doi: 10.1038/s41467-021-21860-7. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/33750801/)

11. X Xu, B Wang, Z Jiang, Q Chen, K Mao, X Shi, C Yan, J Hu, Y Zha, C Ma, Zhang J, Guo R, **Wang L**, Zhao S, Liu H, Zhang Q, Zhang Y. Novel risk factors for craniofacial microsomia and assessment of their utility in clinic diagnosis. **Hum Mol Genet**. 2021 Feb 22;ddab055. doi:10.1093/hmg/ddab055. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/33615373/)

12. Cutrer FM, Moyer A, Atkinson E, **Wang L**, Tian S, Wu Y, Garza I, Robertson C, Huebert C, Moore B, Klein CJ. Genetic variants related to successful migraine prophylaxis with verapamil. **Molecular Genetics & Genomic Medicine** 2021 Apr 7. doi:https://doi.org/10.1002/mgg3.1680. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/33829662/)

### 2020

1. Du M, Tian Y, Tan W, Wang L, **Wang L**, Kilari D, Huang CC, Wang L, Kohli M. Plasma cell-free DNA-based predictors of response to abiraterone acetate/prednisone and prognostic factors in metastatic castration-resistant prostate cancer. ***Prostate Cancer Prostatic Dis***. 2020 Mar 18. doi: 10.1038/s41391-020-0224-4. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/32203070/)

2. Liu L, Wang G, **Wang L**, Yu C, Li M, Song S, Hao L, Ma L, Zhang Z. Computational identification and characterization of glioma candidate biomarkers through multi-omics integrative profiling. ***Biol Direct***. 2020 Jun 15; 15 (1):10 Epub 2020 June 15. doi: 10.1186/s13062-020-00264-5. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/32539851/)

3. Li Y, **Wang L**#. RNA Coding Potential Prediction Using Alignment-Free Logistic Regression Model.  ***Methods Mol Biol*** (book chapter). 2020 Dec 17. doi: 10.1007/978-1-0716-1158-6_3. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/33326068/)

### 2019

1. Wei T, Nie J, Larson NB, Ye Z, Eckel Passow JE, Robertson KD, Kocher JA, **Wang L**#. CpGtools: A Python Package for DNA Methylation Analysis. ***Bioinformatics***. 2019 Dec 6 Epub 2019 Dec 06. doi: 10.1093/bioinformatics/btz916. [View PubMed](https://pubmed.ncbi.nlm.nih.gov//)

2. Wang G, Yin H, Li B, Yu C, Wang F, Xu X, Cao J, Bao Y, **Wang L**, Abbasi AA, Bajic VB, Ma L, Zhang Z. Characterization and identification of long non-coding RNAs based on feature relationship. ***Bioinformatics***. 2019 Sep 1; 35 (17):2949-2956. doi: 10.1093/bioinformatics/btz008. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/31808791/)

3. **Wang L**\*, Marek GW 3rd\*, Hlady RA\*, Wagner RT, Zhao X, Clark VC, Fan AX, Liu C, Brantly M, Robertson KD. Alpha-1 Antitrypsin Deficiency Liver Disease, Mutational Homogeneity Modulated by Epigenetic Heterogeneity With Links to Obesity. ***Hepatology***. 2019 Jul; 70 (1):51-66 Epub 2019 Mar 20. doi: 10.1002/hep.30526. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/30681738/)

4. Zhao Y, Ding L, Wang D, Ye Z, He Y, Ma L, Zhu R, Pan Y, Wu Q, Pang K, Hou X, Weroha SJ, Han C, Coleman R, Coleman I, Karnes RJ, Zhang J, Nelson PS, **Wang L**, Huang H. EZH2 cooperates with gain-of-function p53 mutants to promote cancer growth and metastasis. ***EMBO J***. 2019 Mar 1; 38 (5) Epub 2019 Feb 05. doi: 10.15252/embj.201899599. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/30723117/)

5. Jimenez RE, Atwell TD, Sicotte H, Eckloff B, **Wang L**, Barman P, Sinnwell JP, Eiken PW, McMenomy BP, Tan W, Wang L, Carlson RE, Kohli M. A Prospective Correlation of Tissue Histopathology With Nucleic Acid Yield in Metastatic Castration-Resistant Prostate Cancer Biopsy Specimens. ***Mayo Clin Proc Innov Qual Outcomes***. 2019 Mar; 3 (1):14-22 Epub 2019 Feb 26. doi: 10.1016/j.mayocpiqo.2018.12.005. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/30899904/)

6. Jin X, Ding D, Yan Y, Li H, Wang B, Ma L, Ye Z, Ma T, Wu Q, Rodrigues DN, Kohli M, Jimenez R, **Wang L**, Goodrich DW, de Bono J, Dong H, Wu H, Zhu R, Huang H. Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-kappaB Activation and PD-L1 Expression. ***Mol Cell***. 2019 Jan 3; 73 (1):22-35.e6 Epub 2018 Dec 06. Doi: 10.1016/j.molcel.2018.10.034. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/30527665/)

7. Ma T, Ye Z, **Wang L**#. Genome Wide Approaches to Identify Protein-DNA Interactions. ***Curr Med Chem***. 2019; 26 (42):7641-7654. doi: 10.2174/0929867325666180530115711. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/29848263/)

### 2018

1. Blee AM, He Y, Yang Y, Ye Z, Yan Y, Pan Y, Ma T, Dugdale J, Kuehn E, Kohli M, Jimenez R, Chen Y, Xu W, **Wang L**#, Huang H. TMPRSS2-ERG Controls Luminal Epithelial Lineage and Antiandrogen Sensitivity in PTEN and TP53-Mutated Prostate Cancer. ***Clin Cancer Res***. 2018 Sep 15; 24 (18):4551-4565 Epub 2018 May 29. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/29844131/)


2. Kohli M, Li J, Du M, Hillman DW, Dehm SM, Tan W, Carlson R, Campion MB, **Wang L**, Wang L, Zhang H, Zhang P, Kilari D, Huang CC, Wang L. Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients. ***Prostate Cancer Prostatic Dis***. 2018 Sep; 21 (3):411-418 Epub 2018 June 01. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/29858592/)

3. Xu Y, Lee JH, Li Z, **Wang L**, Ordog T, Bailey RC. A droplet microfluidic platform for efficient enzymatic chromatin digestion enables robust determination of nucleosome positioning. ***Lab Chip***. 2018 Aug 21; 18 (17):2583-2592. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/30046796/)

4. Jin X, Yan Y, Wang D, Ding D, Ma T, Ye Z, Jimenez R, **Wang L**, Wu H, Huang H. DUB3 Promotes BET Inhibitor Resistance and Cancer Progression by Deubiquitinating BRD4. ***Mol Cell***. 2018 Aug 16; 71 (4):592-605.e4 Epub 2018 July 26. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/30057199/)

5. Gao P, Xia JH, Sipeky C, Dong XM, Zhang Q, Yang Y, Zhang P, Cruz SP, Zhang K, Zhu J, Lee HM, Suleman S, Giannareas N, Liu S, Tammela TLJ, Auvinen A, Wang X, Huang Q, **Wang L**, Manninen A, Vaarala MH, Wang L, Schleutker J, Wei GH, PRACTICAL Consortium. Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus. ***Cell***. 2018 Jul 26; 174 (3):576-589.e18 Epub 2018 July 19. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/30033361/)

6. Ye Z, Dong H, Li Y, Ma T, Huang H, Leong HS, Eckel-Passow J, Kocher JA, Liang H, **Wang L**#. Prevalent Homozygous Deletions of Type I Interferon and Defensin Genes in Human Cancers Associate with Immunotherapy Resistance. ***Clin Cancer Res***. 2018 Jul 15; 24 (14):3299-3308 Epub 2018 Apr 04. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/29618619/)

7. Qin S, Liu D, Kohli M, **Wang L**, Vedell PT, Hillman DW, Niu N, Yu J, Weinshilboum RM, Wang L. TSPYL Family Regulates CYP17A1 and CYP3A4 Expression: Potential Mechanism Contributing to Abiraterone Response in Metastatic Castration-Resistant Prostate Cancer. ***Clin Pharmacol Ther***. 2018 Jul; 104 (1):201-210 Epub 2017 Nov 22. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/29027195/)

8. Yan Y, An J, Yang Y, Wu D, Bai Y, Cao W, Ma L, Chen J, Yu Z, He Y, Jin X, Pan Y, Ma T, Wang S, Hou X, Weroha SJ, Karnes RJ, Zhang J, Westendorf JJ, **Wang L**, Chen Y, Xu W, Zhu R, Wang D, Huang H. Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in PTEN- or SPOP-mutated prostate cancer. ***EMBO Mol Med***. 2018 Apr; 10 (4). [View PubMed](https://pubmed.ncbi.nlm.nih.gov/29523594/)

9. Ren S\*, Wei GH\*, Liu D\*, **Wang L**\*, Hou Y, Zhu S, Peng L, Zhang Q, Cheng Y, Su H, Zhou X, Zhang J, Li F, Zheng H, Zhao Z, Yin C, He Z, Gao X, Zhau HE, Chu CY, Wu JB, Collins C, Volik SV, Bell R, Huang J, Wu K, Xu D, Ye D, Yu Y, Zhu L, Qiao M, Lee HM, Yang Y, Zhu Y, Shi X, Chen R, Wang Y, Xu W, Cheng Y, Xu C, Gao X, Zhou T, Yang B, Hou J, Liu L, Zhang Z, Zhu Y, Qin C, Shao P, Pang J, Chung LWK, Xu J, Wu CL, Zhong W, Xu X, Li Y, Zhang X, Wang J, Yang H, Wang J, Huang H, Sun Y. Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression. ***Eur Urol***. 2018 Mar; 73 (3):322-339 Epub 2017 Sept 18. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/28927585/)

10. He Y, Lu J, Ye Z, Hao S, Wang L, Kohli M, Tindall DJ, Li B, Zhu R, **Wang L**#, Huang H. Androgen receptor splice variants bind to constitutively open chromatin and promote abiraterone-resistant growth of prostate cancer. ***Nucleic Acids Res***. 2018 Feb 28; 46 (4):1895-1911. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/29309643/)

11. **Wang L**\*, Dehm SM, Hillman DW, Sicotte H, Tan W, Gormley M, Bhargava V, Jimenez R, Xie F, Yin P, Qin S, Quevedo F, Costello BA, Pitot HC, Ho T, Ho T, Bryce AH, Ye Z, Li Y, Eiken P, Vedell PT, Barman P, McMenomy BP, Atwell TD, Carlson RE, Ellingson M, Eckloff BW, Qin R, Ou F, Hart SN, Huang H, Jen J, Wieben ED, Kalari KR, Weinshilboum RM, Wang L, Kohli M. A prospective genome-wide study of prostate cancer metastases reveals association of wnt pathway activation and increased cell cycle proliferation with primary resistance to abiraterone acetate-prednisone. ***Ann Oncol***. 2018 Feb 1; 29 (2):352-360. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/29069303/)

12. He Y, Zhao Y, **Wang L**, Bohrer LR, Wang L, Pan Y, Wang L, Huang H. LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation. ***Oncogene***. 2018 Jan 25; 37 (4):534-543 Epub 2017 Oct 09. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/28991226/)

### 2017

1. Zhang X, Saarinen AM, Hitosugi T, Wang Z, **Wang L**, Ho TH, Liu J. Inhibition of intracellular lipolysis promotes human cancer cell adaptation to hypoxia. ***Elife***. 2017 Dec 19; 6. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/29256392/)

2. Zhang P, Wang D, Zhao Y, Ren S, Gao K, Ye Z, Wang S, Pan CW, Zhu Y, Yan Y, Yang Y, Wu D, He Y, Zhang J, Lu D, Liu X, Yu L, Zhao S, Li Y, Lin D, Wang Y, **Wang L**, Chen Y, Sun Y, Wang C, Huang H. Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation. ***Nat Med***. 2017 Sep; 23 (9):1055-1062 Epub 2017 Aug 14. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/28805822/)

3. Jin X, Pan Y, **Wang L**, Ma T, Zhang L, Tang AH, Billadeau DD, Wu H, Huang H. Fructose-1,6-bisphosphatase Inhibits ERK Activation and Bypasses Gemcitabine Resistance in Pancreatic Cancer by Blocking IQGAP1-MAPK Interaction. ***Cancer Res***. 2017 Aug 15; 77 (16):4328-4341 Epub 2017 July 18. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/28720574/)

4. Kohli M, Ho Y, Ho Y, Hillman DW, Van Etten JL, Henzler C, Yang R, Sperger JM, Li Y, Tseng E, Hon T, Clark T, Tan W, Carlson RE, **Wang L**, Sicotte H, Thai H, Jimenez R, Huang H, Vedell PT, Eckloff BW, Quevedo JF, Pitot HC, Costello BA, Jen J, Wieben ED, Silverstein KAT, Lang JM, Wang L, Dehm SM. Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone Resistance. ***Clin Cancer Res***. 2017 Aug 15; 23 (16):4704-4715 Epub 2017 May 04. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/28473535/)

5. Ye Z, Ma T, Kalmbach MT, Dasari S, Kocher JA, **Wang L**#. CircularLogo: A lightweight web application to visualize intra-motif dependencies. ***BMC Bioinformatics***. 2017 May 22; 18 (1):269. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/28532394/)

6. Pan CW, Jin X, Zhao Y, Pan Y, Yang J, Karnes RJ, Zhang J, **Wang L**, Huang H. AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interaction. ***EMBO J***. 2017 Apr 13; 36 (8):995-1010 Epub 2017 Mar 09. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/28279977/)

7. Jin X, Pan Y, **Wang L**, Zhang L, Ravichandran R, Potts PR, Jiang J, Wu H, Huang H. MAGE-TRIM28 complex promotes the Warburg effect and hepatocellular carcinoma progression by targeting FBP1 for degradation. ***Oncogenesis***. 2017 Apr 10; 6 (4):e312. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/28394358/)

8. McNair C, Urbanucci A, Comstock CE, Augello MA, Goodwin JF, Launchbury R, Zhao SG, Schiewer MJ, Ertel A, Karnes J, Davicioni E, **Wang L**, Wang Q, Mills IG, Feng FY, Li W, Carroll JS, Knudsen KE. Cell cycle-coupled expansion of AR activity promotes cancer progression. ***Oncogene***. 2017 Mar 23; 36 (12):1655-1668 Epub 2016 Sept 26. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/27669432/)

9. Ho TH, Serie DJ, Parasramka M, Cheville JC, Bot BM, Tan W, **Wang L**, Joseph RW, Hilton T, Leibovich BC, Parker AS, Eckel-Passow JE. Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes. ***Ann Oncol***. 2017 Mar 1; 28 (3):604-610. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/27993815/)


### 2016

1. He Y, Peng S, Wang J, Chen H, Cong X, Chen A, Hu M, Qin M, Wu H, Gao S, **Wang L**, Wang X, Yi Z, Liu M. Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer. ***Nat Commun***. 2016 Dec 13; 7:13122. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/27959342/)

2. Zhao J, Zhao Y, **Wang L**, Wang L, Zhang J, Karnes RJ, Kohli M, Wang G, Huang H. Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer. ***Oncotarget***. 2016 Jun 21; 7 (25):38551-38565. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/27221037/)

3. Blee AM, Liu S, **Wang L**, Huang H. BET bromodomain-mediated interaction between ERG and BRD4 promotes prostate cancer cell invasion. ***Oncotarget***. 2016 Jun 21; 7 (25):38319-38332. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/27223260/)

4. Pan CW, Liu H, Zhao Y, Qian C, **Wang L**, Qi J. JNK2 downregulation promotes tumorigenesis and chemoresistance by decreasing p53 stability in bladder cancer. ***Oncotarget***. 2016 Jun 7; 7 (23):35119-31. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/27147566/)

5. Zhao Y, **Wang L**, Ren S, Wang L, Blackburn PR, McNulty MS, Gao X, Qiao M, Vessella RL, Kohli M, Zhang J, Karnes RJ, Tindall DJ, Kim Y, MacLeod R, Ekker SC, Kang T, Sun Y, Huang H. Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate Cancer. ***Cell Rep***. 2016 Apr 19; 15 (3):599-610 Epub 2016 Apr 07. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/27068475/)

6. Hart SN, Ellingson MS, Schahl K, Vedell PT, Carlson RE, Sinnwell JP, Barman P, Sicotte H, Eckel-Passow JE, **Wang L**, Kalari KR, Qin R, Kruisselbrink TM, Jimenez RE, Bryce AH, Tan W, Weinshilboum R, Wang L, Kohli M. Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer. ***BMJ Open***. 2016 Apr 15; 6 (4):e010332. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/27084275/)

7. **Wang L**\*, Nie J\*, Sicotte H, Li Y, Eckel-Passow JE, Dasari S, Vedell PT, Barman P, Wang L, Weinshiboum R, Jen J, Huang H, Kohli M, Kocher JP. Measure transcript integrity using RNA-seq data. ***BMC Bioinformatics***. 2016 Feb 3; 17:58 Epub 2016 Feb 03. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/26842848/)

### 2015

1. Wang D, Ding L, **Wang L**, Zhao Y, Sun Z, Karnes RJ, Zhang J, Huang H. LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer. Oncotarget. 2015 Dec 1; 6 (38):41045-55. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/26516927/)

2. An J, Ren S, Murphy SJ, Dalangood S, Chang C, Pang X, Cui Y, **Wang L**, Pan Y, Zhang X, Zhu Y, Wang C, Halling GC, Cheng L, Sukov WR, Karnes RJ, Vasmatzis G, Zhang Q, Zhang J, Cheville JC, Yan J, Sun Y, Huang H. Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation. ***Mol Cell***. 2015 Sep 17; 59 (6):904-16 Epub 2015 Sept 03. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/26344096/)

3. **Wang L**\*, Nie JJ, Kocher JP. PVAAS: identify variants associated with aberrant splicing from RNA-seq. ***Bioinformatics***. 2015 May 15; 31 (10):1668-70 Epub 2015 Jan 07. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/25573917/)

4. Chen Z, Lan X, Thomas-Ahner JM, Wu D, Liu X, Ye Z, **Wang L**, Sunkel B, Grenade C, Chen J, Zynger DL, Yan PS, Huang J, Nephew KP, Huang TH, Lin S, Clinton SK, Li W, Jin VX, Wang Q. Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer. ***EMBO J***. 2015 Feb 12; 34: (4)502-16. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/25535248/)

5. Lu J, Lonergan PE, Nacusi LP, **Wang L**, Schmidt LJ, Sun Z, Van der Steen T, Boorjian SA, Kosari F, Vasmatzis G, Klee GG, Balk SP, Huang H, Wang C, Tindall DJ. The cistrome and gene signature of androgen receptor splice variants in castration resistant prostate cancer cells. ***J Urol***. 2015 Feb; 193 (2):690-8 Epub 2014 Aug 14. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/25132238/)

6. Kohli M\*#, **Wang L**\*#, Xie F, Sicotte H, Yin P, Dehm SM, Hart SN, Vedell PT, Barman P, Qin R, Mahoney DW, Carlson RE, Eckel-Passow JE, Atwell TD, Eiken PW, McMenomy BP, Wieben ED, Jha G, Jimenez RE, Weinshilboum R, Wang L. Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide Therapy. ***PLoS One***. 2015; 10 (12):e0145176 Epub 2015 Dec 22. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/26695660/)

7. **Wang L**\*, Huang H\*, Dougherty G, Zhao Y, Hossain A, Kocher JP. Epidaurus: aggregation and integration analysis of prostate cancer epigenome. ***Nucleic Acids Res***. 2015 Jan; 43 (2):e7 Epub 2014 Nov 05. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/25378314/)


### 2014

1. **Wang L**\*#, Chen J, Wang C, Uuskula-Reimand L, Chen K, Medina-Rivera A, Young EJ, Zimmermann MT, Yan H, Sun Z, Zhang Y, Wu ST, Huang H, Wilson MD, Kocher JP, Li W. MACE: model based analysis of ChIP-exo. ***Nucleic Acids Res***. 2014 Nov 10; 42 (20):e156 Epub 2014 Sept 23. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/25249628/)

2. Sowalsky AG, Xia Z, **Wang L**, Zhao H, Chen S, Bubley GJ, Balk SP, Li W. Whole Transcriptome Sequencing Reveals Extensive Unspliced mRNA in Metastatic Castration-Resistant Prostate Cancer. ***Mol Cancer Res***. 2014 Sep 04. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/25189356/)

3. Yan H, Evans J, Kalmbach M, Moore R, Middha S, Luban S, **Wang L**, Bhagwate A, Li Y, Sun Z, Chen X, Kocher JP. HiChIP: a high-throughput pipeline for integrative analysis of ChIP-Seq data. ***BMC Bioinformatics***. 2014 Aug 15; 15:280. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/25128017/)

4. Blackmore JK, Karmakar S, Gu G, Chaubal V, **Wang L**, Li W, Smith CL. The SMRT Coregulator Enhances Growth of Estrogen Receptor-alpha-Positive Breast Cancer Cells by Promotion of Cell Cycle Progression and Inhibition of Apoptosis. ***Endocrinology***. 2014 Jun 27; en20141002. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/24971610/)

5. Zhao H, Sun Z, Wang J, Huang H, Kocher JP, **Wang L**#. CrossMap: a versatile tool for coordinate conversion between genome assemblies. ***Bioinformatics***. 2014 Apr 1; 30 (7):1006-7 Epub 2013 Dec 18. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/24351709/)

6. Adikesavan AK, Karmakar S, Pardo P, **Wang L**, Liu S, Li W, Smith CL. Activation of p53 transcriptional activity by SMRT: a histone deacetylase 3-independent function of a transcriptional corepressor. ***Mol Cell Biol***. 2014 Apr; 34 (7):1246-61 Epub 2014 Jan 21. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/24449765/)

7. Ding L, Chen S, Liu P, Pan Y, Zhong J, Regan KM, **Wang L**, Yu C, Rizzardi A, Cheng L, Zhang J, Schmechel SC, Cheville JC, Van Deursen J, Tindall DJ, Huang H. CBP loss cooperates with PTEN haploinsufficiency to drive prostate cancer: implications for epigenetic therapy. ***Cancer Res***. 2014 Apr 1; 74 (7):2050-61 Epub 2014 Feb 03. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/24491799/)

### 2013

1. Wang L, Zeng X, Chen S, Ding L, Zhong J, Zhao JC, **Wang L**, Sarver A, Koller A, Zhi J, Ma Y, Yu J, Chen J, Huang H. BRCA1 is a negative modulator of the PRC2 complex. ***EMBO J***. 2013 May 29; 32 (11):1584-97 Epub 2013 Apr 26. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/23624935/)

2. **Wang L**\*, Park HJ\*, Dasari S, Wang S, Kocher JP, Li W. CPAT: Coding-Potential Assessment Tool using an alignment-free logistic regression model. ***Nucleic Acids Res***. 2013 Apr 1; 41 (6):e74 Epub 2013 Jan 17. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/23335781/)

3. Sun Z, Asmann YW, Nair A, Zhang Y, **Wang L**, Kalari KR, Bhagwate AV, Baker TR, Carr JM, Kocher JP, Perez EA, Thompson EA. Impact of library preparation on downstream analysis and interpretation of RNA-Seq data: comparison between Illumina PolyA and NuGEN Ovation protocol. ***PLoS One***. 2013; 8 (8):e71745 Epub 2013 Aug 19. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/23977132/)

4. Rijnkels M, Freeman-Zadrowski C, Hernandez J, Potluri V, **Wang L**, Li W, Lemay DG. Epigenetic modifications unlock the milk protein gene loci during mouse mammary gland development and differentiation. ***PLoS One***. 2013; 8 (1):e53270 Epub 2013 Jan 02. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/23301053/)

### 2012

1. **Wang L**\*, Wang S, Li W. RSeQC: quality control of RNA-seq experiments. Bioinformatics. 2012 Aug 15; 28(16):2184-5. Epub 2012 Jun 27. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/22743226/)

### 2011

2. Zhang C\*, **Wang L**\*, Wu D, Chen H, Chen Z, Thomas-Ahner JM, Zynger DL, Eeckhoute J, Yu J, Luo J, Brown M, Clinton SK, Nephew KP, Huang TH, Li W, Wang Q. Definition of a FoxA1 Cistrome that is crucial for G1 to S-phase cell-cycle transit in castration-resistant prostate cancer. ***Cancer Res***. 2011 Nov 1; 71(21):6738-48. Epub 2011 Sep 07. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/21900400/)

3. Kannan K\*, **Wang L**\*, Wang J, Ittmann MM, Li W, Yen L. Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing. ***Proc Natl Acad Sci U S A***. 2011 May 31; 108(22):9172-7. Epub 2011 May 12. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/21571633/)

4. Klisch TJ, Xi Y, Flora A, **Wang L**, Li W, Zoghbi HY. In vivo Atoh1 targetome reveals how a proneural transcription factor regulates cerebellar development. ***Proc Natl Acad Sci U S A***. 2011 Feb 22; 108(8):3288-93. Epub 2011 Feb 07. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/21300888/)

5. Daines B\*, Wang H\*, **Wang L**\*, Li Y, Han Y, Emmert D, Gelbart W, Wang X, Li W, Gibbs R, Chen R. The Drosophila melanogaster transcriptome by paired-end RNA sequencing. ***Genome Res***. 2011 Feb; 21(2):315-24. Epub 2010 Dec 22. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/21177959/)


### 2010

1. Chen Z\*, **Wang L**\*, Wang Q, Li W. Histone modifications and chromatin organization in prostate cancer. ***Epigenomics***. 2010 Aug; 2(4):551-60. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/21318127/)

2. Lanz RB, Bulynko Y, Malovannaya A, Labhart P, **Wang L**, Li W, Qin J, Harper M, O'Malley BW. Global characterization of transcriptional impact of the SRC-3 coregulator. ***Mol Endocrinol***. 2010 Apr; 24(4):859-72. Epub 2010 Feb 24. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/20181721/)

3. **Wang L**\*, Xi Y, Yu J, Dong L, Yen L, Li W. A statistical method for the detection of alternative splicing using RNA-seq. ***PLoS One***. 2010; 5(1):e8529. Epub 2010 Jan 08. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/20072613/)

### 2009

1. **Wang L**\*, Hao L, Li X, Hu S, Ge S, Yu J. SNP deserts of Asian cultivated rice: genomic regions under domestication. ***J Evol Biol***. 2009 Apr; 22(4):751-61. Epub 2009 Feb 23. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/19243488/)

2. Li X, Tan L, **Wang L**, Hu S, Sun C. Isolation and characterization of conserved non-coding sequences among rice (Oryza sativa L.) paralogous regions. ***Mol Genet Genomics***. 2009 Jan; 281(1):11-8. Epub 2008 Sep 30. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/18825415/)


### 2008

1. Wang W, Meng B, Ge X, Song S, Yang Y, Yu X, **Wang L**, Hu S, Liu S, Yu J. Proteomic profiling of rice embryos from a hybrid rice cultivar and its parental lines. ***Proteomics***. 2008 Nov; 8(22):4808-21. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/18850630/)



## Book Chapter
----------------

1. Li X, Nair A, Wang S, **Wang L**#. Quality control of RNA-seq experiments. ***Methods Mol Biol*** (Springer). 2015; 1269:137-46. [View PubMed](https://pubmed.ncbi.nlm.nih.gov/25577376/)

2. L. Y, **Wang L**#. RNA coding potential prediction using alignment-free logistic regression model. (Springer). [View PubMed](https://pubmed.ncbi.nlm.nih.gov/33326068/)

## Other resources

- [Mayo Clinic Profile](https://www.mayo.edu/research/faculty/wang-liguo-ph-d/bio-00055202)
- [Google Scholar Profile](https://scholar.google.com/citations?user=9sQzL0IAAAAJ&hl=en)
- [My NCBI Bibliography](https://www.ncbi.nlm.nih.gov/myncbi/1rKnDv7Czr9Qi/bibliography/public/)
